Seastar Medical Provides Updates On Enrollment Of Adult Pivotal Clinical Study And Commercial Launch Of Quelimmune, FDA-Approved In Pediatric Patients

  • Kevin Chung

Press/Media

Period12 Mar 2024

Media coverage

1

Media coverage

  • TitleSeastar Medical Provides Updates On Enrollment Of Adult Pivotal Clinical Study And Commercial Launch Of Quelimmune, FDA-Approved In Pediatric Patients
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date12/03/24
    PersonsKevin Chung